These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 35225565)

  • 61. Mucormycosis-Related Vision Loss in COVID-19.
    Dhoot SK
    Ophthalmic Surg Lasers Imaging Retina; 2022 Mar; 53(3):173-174. PubMed ID: 35272556
    [No Abstract]   [Full Text] [Related]  

  • 62. Rising incidence of mucormycosis in patients with COVID-19: another challenge for India amidst the second wave?
    Raut A; Huy NT
    Lancet Respir Med; 2021 Aug; 9(8):e77. PubMed ID: 34090607
    [No Abstract]   [Full Text] [Related]  

  • 63. Rhino-orbito-cerebral mucormycosis caused by Rhizopus microsporus var. microsporus in a diabetic patient with COVID-19.
    Munhoz SD; Lellis RF; Reis APC; Del Negro GMB; Sousa MGT; Veasey JV
    An Bras Dermatol; 2022; 97(4):501-504. PubMed ID: 35691738
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Mucormycosis in COVID-19 patients: predisposing factors, prevention and management.
    Rudrabhatla PK; Reghukumar A; Thomas SV
    Acta Neurol Belg; 2022 Apr; 122(2):273-280. PubMed ID: 34820787
    [TBL] [Abstract][Full Text] [Related]  

  • 65. ECMM/ISHAM recommendations for clinical management of COVID-19 associated mucormycosis in low- and middle-income countries.
    Rudramurthy SM; Hoenigl M; Meis JF; Cornely OA; Muthu V; Gangneux JP; Perfect J; Chakrabarti A;
    Mycoses; 2021 Sep; 64(9):1028-1037. PubMed ID: 34133816
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Intestinal mucormycosis in a patient with COVID-19: A case report.
    Paliwal P; Rahar S; Sharma A; Gupta D; Ahuja A; Chauhan DS
    Indian J Pathol Microbiol; 2022; 65(2):475-477. PubMed ID: 35435400
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Rising concerns of Mucormycosis (Zygomycosis) among COVID-19 patients; an analysis and review based on case reports in literature.
    Ramphul K; Verma R; Kumar N; Ramphul Y; Mejias S; Lohana P
    Acta Biomed; 2021 Sep; 92(4):e2021271. PubMed ID: 34487063
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Dual hit - Magnetic resonance imaging in concomitant anterior and posterior ischemic optic neuropathy in a case of rhino-orbital mucormycosis and COVID-19.
    Kaushik KS; Acharya UV; Krupa L
    Indian J Ophthalmol; 2022 Jan; 70(1):300-301. PubMed ID: 34937262
    [No Abstract]   [Full Text] [Related]  

  • 69. A case report of rhino-facial mucormycosis in a non-diabetic patient with COVID-19: a systematic review of literature and current update.
    Mohammadi F; Badri M; Safari S; Hemmat N
    BMC Infect Dis; 2021 Sep; 21(1):906. PubMed ID: 34479495
    [TBL] [Abstract][Full Text] [Related]  

  • 70. "MuCovid-21" study: Mucormycosis at an Indian tertiary care centre during the COVID-19 pandemic.
    Kumar S; Choudhary R; Pandey VP
    J R Coll Physicians Edinb; 2021 Dec; 51(4):352-358. PubMed ID: 34882132
    [TBL] [Abstract][Full Text] [Related]  

  • 71. An Instructive Case of Cerebral Mucormycosis.
    Shao B; Hagan MJ; Sastry RA; Kritselis M; Donahue JE; Toms SA
    R I Med J (2013); 2022 Mar; 105(2):8-12. PubMed ID: 35211702
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Epidemiology, clinical profile, management, and outcome of COVID-19-associated rhino-orbital-cerebral mucormycosis in 2826 patients in India - Collaborative OPAI-IJO Study on Mucormycosis in COVID-19 (COSMIC), Report 1.
    Sen M; Honavar SG; Bansal R; Sengupta S; Rao R; Kim U; Sharma M; Sachdev M; Grover AK; Surve A; Budharapu A; Ramadhin AK; Tripathi AK; Gupta A; Bhargava A; Sahu A; Khairnar A; Kochar A; Madhavani A; Shrivastava AK; Desai AK; Paul A; Ayyar A; Bhatnagar A; Singhal A; Nikose AS; Bhargava A; Tenagi AL; Kamble A; Nariani A; Patel B; Kashyap B; Dhawan B; Vohra B; Mandke C; Thrishulamurthy C; Sambare C; Sarkar D; Mankad DS; Maheshwari D; Lalwani D; Kanani D; Patel D; Manjandavida FP; Godhani F; Agarwal GA; Ravulaparthi G; Shilpa GV; Deshpande G; Thakkar H; Shah H; Ojha HR; Jani H; Gontia J; Mishrikotkar JP; Likhari K; Prajapati K; Porwal K; Koka K; Dharawat KS; Ramamurthy LB; Bhattacharyya M; Saini M; Christy MC; Das M; Hada M; Panchal M; Pandharpurkar M; Ali MO; Porwal M; Gangashetappa N; Mehrotra N; Bijlani N; Gajendragadkar N; Nagarkar NM; Modi P; Rewri P; Sao P; Patil PS; Giri P; Kapadia P; Yadav P; Bhagat P; Parekh R; Dyaberi R; Chauhan RS; Kaur R; Duvesh RK; Murthy R; Dandu RV; Kathiara R; Beri R; Pandit R; Rani RH; Gupta R; Pherwani R; Sapkal R; Mehta R; Tadepalli S; Fatima S; Karmarkar S; Patil SS; Shah S; Shah S; Shah S; Dubey S; Gandhi S; Kanakpur S; Mohan S; Bhomaj S; Kerkar S; Jariwala S; Sahu S; Tara S; Maru SK; Jhavar S; Sharma S; Gupta S; Kumari S; Das S; Menon S; Burkule S; Nisar SP; Kaliaperumal S; Rao S; Pakrasi S; Rathod S; Biradar SG; Kumar S; Dutt S; Bansal S; Ravani SA; Lohiya S; Ali Rizvi SW; Gokhale T; Lahane TP; Vukkadala T; Grover T; Bhesaniya T; Chawla U; Singh U; Une VL; Nandedkar V; Subramaniam V; Eswaran V; Chaudhry VN; Rangarajan V; Dehane V; Sahasrabudhe VM; Sowjanya Y; Tupkary Y; Phadke Y;
    Indian J Ophthalmol; 2021 Jul; 69(7):1670-1692. PubMed ID: 34156034
    [TBL] [Abstract][Full Text] [Related]  

  • 73. COVID-19-associated mucormycosis: Preliminary report from a tertiary eye care centre.
    Walia S; Bhaisare V; Rawat P; Kori N; Sharma M; Gupta N; Urdhwareshwar S; Thakur S; Arya N
    Indian J Ophthalmol; 2021 Dec; 69(12):3685-3689. PubMed ID: 34827023
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Mucormycosis, The Deadly New Worry to COVID-19 Pandemic.
    Kamrul-Hasan AB; Selim S
    Mymensingh Med J; 2021 Jul; 30(3):874-880. PubMed ID: 34226483
    [TBL] [Abstract][Full Text] [Related]  

  • 75. A Novel Study of Correlation of Lipid Parameters with Clinical Profile, Staging and Onset of Rhino Orbito Cerebral Mucormycosis Covid 19 Pandemic.
    V V; St K
    J Assoc Physicians India; 2022 Apr; 70(4):11-12. PubMed ID: 35443508
    [TBL] [Abstract][Full Text] [Related]  

  • 76. COVID-19 and mucormycosis superinfection: the perfect storm.
    Al-Tawfiq JA; Alhumaid S; Alshukairi AN; Temsah MH; Barry M; Al Mutair A; Rabaan AA; Al-Omari A; Tirupathi R; AlQahtani M; AlBahrani S; Dhama K
    Infection; 2021 Oct; 49(5):833-853. PubMed ID: 34302291
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Rise of the phoenix: Mucormycosis in COVID-19 times.
    Ravani SA; Agrawal GA; Leuva PA; Modi PH; Amin KD
    Indian J Ophthalmol; 2021 Jun; 69(6):1563-1568. PubMed ID: 34011742
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Post-COVID-19 mucormycosis presenting as chest wall cellulitis with mediastinitis.
    Arora N; Gudipati A; Kundu R; Prabhakar N; Suri V; Malhotra P; Jain A
    Lancet Infect Dis; 2021 Nov; 21(11):1611. PubMed ID: 34717815
    [No Abstract]   [Full Text] [Related]  

  • 79. Rhino-orbital mucormycosis: Our experiences with clinical features and management in a tertiary care center.
    Singh SP; Rana J; Singh VK; Singh R; Sachan R; Singh S; Jain S
    Rom J Ophthalmol; 2021; 65(4):339-353. PubMed ID: 35087975
    [No Abstract]   [Full Text] [Related]  

  • 80. COVID Associated Mucormycosis: A Study on the Spectrum of Clinical, Biochemical and Radiological Findings in A Series of Ten Patients.
    Pal P; Chatterjee N; Ghosh S; Ray BK; Mukhopadhyay P; Bhunia K; Srivastava SR; Adhikari S; Barman D; Banerjee B; Mukhopadhyay M; Pal J
    J Assoc Physicians India; 2021 Oct; 69(10):11-12. PubMed ID: 34781648
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.